Abstract In this study, the distribution patterns of P2Y 1 , P2Y 2 P2Y 4 , P2Y 6 , P2Y 12 , and P2Y 13 receptors in the anterior pituitary cells of rat were studied with doublelabeling immunofluorescence and Western blot. The results showed that P2Y receptors were widely expressed in the anterior pituitary. P2Y 1 and P2Y 4 receptors were found to be expressed in the majority of gonadotrophs and thyrotrophs, P2Y 2 receptors were expressed in a small subpopulation of lactotrophs and almost all the folliculo-stellate cells, that were also stained with S100 protein immunoreactivity. P2Y 6 receptors were expressed in macrophages. P2Y 13 receptors were expressed in a small subpopulation of cells in the rat anterior pituitary, the identity of which needs to be clarified. P2Y 1 and P2Y 4 receptors are co-expressed in some gonadotrophs and thyrotrophs. Corticotrophs and somatotrophs were found not to express P2Y receptors in this study. FSH and TSH were shown to coexist in the same endocrine cells in rat anterior pituitary. The present data suggests that purines and/or pyrimidines could be involved in regulating the functions of gonadotrophs and thyrotrophs via P2Y 1 and P2Y 4 receptors, some lactotrophs via P2Y 2 receptors, and folliculo-stellate cells via P2Y 2 receptors in the rat anterior pituitary.
Introduction
Extracellular purines and pyrimidines act as messengers via purinergic receptors on the plasma membrane. There are two purinergic receptors: P1 receptors (adenosine receptor [AR] ) activated by adenosine and P2 receptors activated by ATP-, ADP-, UTP-and/or UDP. There are four AR subtypes (A 1 , A 2A , A 2B and A 3 ), which are all G protein-coupled receptors. There are two groups of P2 receptors: P2X and P2Y receptors, which are ligand-gated ion channels and G protein-coupled receptors, respectively. So far, seven P2Y receptors and seven P2X receptors have been cloned and are denoted P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , P2Y 12 , P2Y 13 , P2Y 14 , and P2X 1 to P2X 7 receptors [1] .
There is increasing evidence to show that extracellular purines and pyrimidines, via P2 receptors, have important physiological functions in the regulation of anterior pituitary cell secretion. Using the technique of single-cell calcium measurement, the initial characterization of purinoceptors in anterior pituitary cells were identified [2] [3] [4] [5] [6] . These experiments revealed that functional P2X receptors are operative in all secretory cell types. With molecular biology techniques, P2X 2 , P2X 3 , P2X 4 , and P2X 7 mRNA transcripts were detected in a mixed population of anterior pituitary cells. Lactotrophs and immortalized GH3 pituitary cells expressed transcripts for P2X 3 , P2X 4 , and P2X 7 subunits, somatotrophs expressed P2X 2 receptor, and thyrotrophs and corticotrophs also express P2X receptors [7] Single-cell patch-clamp analysis in gonadotrophs from embryonic, neonatal, and adult rats revealed that P2X 2 receptors are operative and involved in release of luteinizing hormone (LH) and regulation of gonadotrophinreleasing hormone (GnRH) controlled electrical activity and secretion [8] . Lactotrophs express P2X 4 receptors, which facilitate Ca 2+ influx and hormone secretion [9] . Compared with data for P2X receptors on the anterior pituitary cells, there is less available data for P2Y receptors on these cells. Using calcium image analysis, sheep and rat anterior pituitary cells were found to express P2Y receptors [10] [11] [12] . Following RT-PCR analysis, P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , and P2Y 12 receptor transcripts were detected in mixed anterior pituitary cells [13, 14] . The identified cells in the anterior pituitary with P2Y receptors were also found in rat pituitary folliculo-stellate cells in primary culture [15] , gonadotrophs [16] and lactotrophs [17] . No detailed immunofluorescence, Western blot or in situ hybridization studies about P2Y receptor subtype expression on the individual cell types in the anterior pituitary are currently available.
In this study, we used single-labeling and doublelabeling immunofluorescence, in situ hybridization and Western blot analyses to study the distribution patterns of P2Y 1 , P2Y 2 P2Y 4 , P2Y 6 , P2Y 12 , and P2Y 13 receptors in anterior pituitary cells of rat and found that gonadotrophs and thyrotrophs express P2Y 1 and P2Y 4 receptors, lactotrophs and folliculo-stellate cells express P2Y 2 , and macrophages express P2Y 6 .
Materials and methods

Animals and tissue preparation
All experimental procedures were approved by the Institutional Animal Care and Use Committee at Second Military Medical University. Five Sprague-Dawley rats were used. Animals were anesthetized by intraperitoneal injection with chloral hydrate and perfused through the aorta with 0.9% NaCl solution and 4% paraformaldehyde in 0.1 mol/l phosphate buffer, pH 7.4. The pituitaries were dissected out and refixed in 4% paraformaldehyde in 0.1 mol/l phosphate buffer pH 7.4 for 4-6 h, then transferred to 25% sucrose in PBS and kept in the solution until they sank to the bottom. Thereafter, the segment blocks were rapidly frozen and crosscut sections (10 μm in thickness) were cut with a Leica cryostat and thawed on slides covered with gelatin. Table 1 shows the primary antibodies used in this study.
Immunohistochemistry
The following protocol is a double immunofluorescence technique for two primary antibodies from different hosts. The section slides were washed 3×5 min in PBS, and then preincubated in antiserum solution 1 (10% normal bovine serum, 0.2% Triton-X-100, 0.4% sodium azide in 0.01 mol/l PBS pH7.2) for 30 min, followed by incubation with two primary antibody dilutions, one a P2Y antibody (P2Y 6 , P2Y 12 , and P2Y 13 ) and the second either a hormonal antibody adrenocorticotropin (ACTH), follicle-stimulating hormone (FSH), prolactin (PRL), and thyroid-stimulating hormone (TSH) or a cell type marker (ED1 [macrophage marker] and S-100 [folliculo-stellate cell marker]) at room temperature, overnight. Subsequently, the sections were incubated at room temperature for 2 h with a mixed secondary antibody solution of Cy3-conjugated donkey anti-rabbit IgG diluted 1:400 for P2Y antibodies and either FITC-conjugated donkey anti-goat IgG diluted 1:200 for hormonal antibodies or FITC-conjugated donkey anti-mouse IgG diluted 1:200 for cell type marker antibodies. All the incubations and reactions were separated by 3× 10 min washes in PBS.
The following protocol is a double immunofluorescence technique for two primary antibodies from the same hosts. Simultaneous detection of two antigens by immunostaining usually requires primary antibodies from two different species. A novel double-labeling immunostaining method for immunodetection of two independent antigens has been described [18] . The principle of the method is that the first antigen is detected by the first primary antibody that is diluted so extensively that it cannot be detected with conventional methods; a highly sensitive tyramide signals amplification (TSA) system is used to identify this antibody; the second antigen is stained with the secondary primary antibody and detected by conventional immunostaining. We have used this double-labeling protocol of fluorescence immunohistochemistry successfully [19, 20] . The following protocol was modified from this protocol. Endogenous peroxidase was blocked by 1% H 2 O 2 in PBS for 30 min. The sections were pre-incubated in 10% normal horse serum (NHS), 0.2% Triton X-100 in PBS for 30 min, followed by incubation with P2Y antibodies diluted in antibody dilution solution (10% NHS, 0.2% Triton X-100 and 0.4% sodium azide in PBS) overnight at 4°C. Subsequently, the sections were incubated with biotinylated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) at a dilution of 1:500 in PBS containing 1% NHS for 1 h. The sections were then incubated in extravidin peroxidase (Sigma) diluted 1:1,000 in PBS for 30 min at room temperature. P2Y immunoreactivity was visualized by the TSA Fluorescein system (NEL701, NEN, USA). After visualization the sections were incubated with the second primary antibody of either a hormone or a cell type marker, diluted in the antiserum dilution solution overnight at 4°C. Subsequently, the sections were incubated with Cy3 conjugated donkeyanti-rabbit or mouse (Jackson ImmunoResearch) diluted 1:400 in antiserum dilution solution for 1 h at room temperature. All the incubations and reactions were separated by 3×10 min washes in PBS. Some sections were counter-stained with 5 μg/ml Hoechst 33342.
Combined use of in situ hybridization and immunofluorescence As the proper antibody for growth hormone could not be obtained for this study, sense and antisense digoxigeninlabeled oligonucleotide probes were synthesised (Sagon, Shanghai, China). The sense and antisense nucleotide sequences are AGGGCATCCAGGCTCTGATGCAG G A G C T G G , C C A G C T C C T G C AT C A G A G C CTGGATGCCCT (GenBank Accession: U62779.1), respectively. In situ hybridization was carried out as following. The sections were heated in 0.01 mol/l citrate buffer pH6.8 in a 92°C water bath for 15 min and cool to room temperature in the same buffer. The sections were rinsed in PBS for 3 min for two times, then incubated in 0.25% acetic anhydride with 0.1 M triethanolamine (pH 8.0) for 10 min at room temperature, followed by washing in 2× saline sodium citrate (SSC) for 10 min. Digoxigeninlabeled oligonucleotides (0.5 μg/ml) of either antisense or sense probe was added to the hybridization solution containing 50% formamide, 10% dextrans sulphate, 0. The following method was used to detect hybridization signals and P2Y receptors. Endogenous peroxidase was blocked by 3% H 2 O 2 in PBS for 30 min. The sections were pre-incubated in 10% NHS, 0.2% Triton X-100 in PBS for 30 min, followed by incubation with two primary antibodies (mouse anti-digoxigenin IgG and one of the P2Y antibodies) diluted in antibody dilution solution overnight at 4°C. Subsequently, the sections were incubated with two secondary antibodies of biotinylated donkey anti-mouse IgG and FITC-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch) at a dilution of 1:500 and 1:200, respectively, in PBS containing 1% NHS for 1 h. The sections were then incubated in extravidin peroxidase (Sigma) diluted 1:1,000 in PBS for 30 min at room temperature. The digoxigenin immunoreactivity was visualized by the TSA Cy3 system (NEL704A, NEN life science, USA). All the incubations and reactions were separated by 3×10 min washes in PBS. Some sections were counter-stained with 5 μg/ml Hoechst 33342.
Western blot
Sprague-Dawley rats were deeply anesthetized by sodium pentobarbital (60 mg/kg) and killed by decapitation. The pituitaries were rapidly removed and lysed with 20 mM Tris-HCl buffer, pH 8.0, containing 1% NP-40, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 0.1% mercaptoethanol, 0.5 mM dithiothreitol, and a mixture of proteinase and phosphatase inhibitors (Sigma). Protein concentration was determined by the BCA protein assay method using bovine serum albumin as standard (BCA protein assay kit from Beyotime). Protein samples (100 μg) were loaded in each lane, separated by SDS-PAGE (10% polyacrylamide gels) and then electrotransferred onto nitrocellulose membranes. The membranes were blocked with 10% non-fat dry milk in Tris-buffered saline for 1 h and incubated overnight at 4°C with the P2Y antibodies diluted 1:200-400 in PBS. The membranes were then incubated with alkaline phosphataseconjugated goat anti-Goat or Rabbit IgG (Beyotime) diluted 1:1,000 in 2% BSA in PBS for 1 h at room temperature. The color development was performed with 400 μg/ml nitro-blue tetrazolium, 200 μg/ml 5-bromo-4-chloro-3-indolyl phosphate and 100 mg/ml levamisole in TSM2 (0.1 mol/l Tris-HCl 2 buffer, pH 9.5, 0.1 mol/l NaCl and 0.05 mol/l MgCl 2 ) in the dark. Bands were scanned using a densitometer (GS-700; Bio-Rad Laboratories).
Photomicroscopy
Images were taken with the Nikon digital camera DXM1200 (Nikon, Japan) attached to a Nikon Eclipse E600 microscope (Nikon). Images were imported into a graphics package (Adobe Photoshop). The two-channel readings for green and red fluorescence were merged by using Adobe Photoshop. The focal plane on the microscope was not adjusted whilst determining whether a particular cell co-localized both P2Y receptors and other markers. Only cells that demonstrated the same morphology, orientation and position when viewed under the two different filters (in the same focal plane) for the detection of Cy3 and FITC were deemed to co-localize both P2Y receptor and other markers.
Quantitative analysis
Quantitative analysis for the P2Y receptors immunostaining in the anterior pituitary was performed as follows: five random fields (each area was 0.36 mm 2 ) for one section were chosen and the number of positive cells was counted and expressed as the positive cell numbers per square millimeter. Five fields for each of five sections from each of five rats were used. The mean number of positive cells/mm 2 from each rat was calculated and data are expressed as the mean±standard error of the mean (n= number of rat).
Results
With double-labeling immunofluorescence and combined in situ hybridization and immunofluorescence, P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , and P2Y 13 receptors were found to be expressed in the different cell types of the rat anterior pituitary. Control experiments and Western blot confirmed the specificity of P2Y 1 , P2Y 2 P2Y 4 , P2Y 6 , P2Y 12 , P2Y 13 receptor immunoreactivity in the anterior pituitary cells of rat.
P2Y 1 receptor-immunoreactive (−ir) cells were generally ovoid in shape with moderate to strong immunostaining, some of P2Y 1 receptor-ir cells were angular in shape with processes ( Fig. 1) . Double-labeling immunofluorescence showed that 90% and 93% of P2Y 1 receptor-ir cells were also immunoreactive for FSH and TSH, respectively, but none of them were immunoreactive for ACTH, PRL or S100 in the anterior pituitary of rat (Fig. 1 ). There were still about 32% of FSH-ir endocrine cells and 35% of TSH-ir endocrine cells, which were not found to express P2Y 1 receptors. Growth hormone (GH) mRNA hybridization signals were also not detected in the P2Y 1 receptor-ir cells in the anterior pituitary (Fig. 1c) . P2Y 2 receptor-ir cells were distributed widely in the rat anterior pituitary, and some of the positive cells with long processes were strongly immunostained and angular in shape (Fig. 2) . Doublelabeling immunofluorescence showed that about 38% of P2Y 2 receptor-ir cells were also immunoreactive for PRL, but none of them were immunoreactive for ACTH, FSH, or TSH. GH mRNA hybridization signals were also not detected in the P2Y 2 receptor-ir cells in the anterior pituitary (Fig. 2c) . About 61% of P2Y 2 receptor-ir cells with strong immuno-labeling were also labeled by the S100 antibody in the anterior pituitary. Almost all of the S100-ir cells were also labeled by the P2Y 2 antibody (Fig. 2f) . The distribution pattern of P2Y 4 receptor-ir cells was very similar with that of the P2Y 1 receptor-ir cells. P2Y 4 receptor-ir cells were also generally ovoid in shape with strong immunostaining (Fig. 3) . Double-labeling immunofluorescence showed that almost all of the P2Y 4 receptor-ir cells were also labeled by FSH or TSH antibodies, but none of them were labeled by ACTH, GH, PRL or S100 antibodies (Fig. 3a, c, d , f). There were about 29% FSH-ir endocrine cells and 36% TSH-ir endocrine cells, which were found not to express P2Y 4 receptors, respectively (Fig. 3b, e) . GH mRNA hybridization signals were not detected in the P2Y 4 receptor-ir cells in the anterior pituitary (Fig. 3c) . P2Y 6 receptor-ir cells were also found in the rat anterior pituitary, but they were very small in size and scattered in the anterior pituitary. These positive cells were not labeled by ACTH, FSH, PRL, TSH or S100 antibodies, or GH oligonucleotide probes, but were labeled by ED1 (a macrophage marker) (Fig. 4a, b, c) . No P2Y 12 receptor-ir cells were detected in the rat pituitary (data not showed). P2Y 13 receptor-ir cells were detected in the anterior and intermediate lobes of the rat pituitary. In the anterior lobe, the number of P2Y 13 receptor-ir cells was relatively low. They were found in clusters formed by a few positive cells. These P2Y 13 receptor-ir cells were not labeled by ACTH, FSH, PRL, TSH, ED1 or S100 antibodies or GH oligonucleotide probes. P2Y 13 receptor-ir cells were also found in the intermediate lobe of the rat pituitary and these P2Y 13 receptor-ir cells were also labeled by the ACTH antibody (Fig. 4d, e, f) . Of the P2Y receptor family members examined in this study, only the P2Y 13 receptor was found to be expressed in the intermediate lobe of the rat pituitary. and S100-ir (green) cells. Note that there were no cells doubled labeled (yellow) with P2Y 1 receptor-and S100-immunoreactivity. All scale bars=60 μm in gonadotrophs, lactotrophs, thyrotrophs and folliculostellate cells in the anterior pituitary. As P2Y 1 and P2Y 4 receptors were found to coexist with FSH or TSH, it implies that P2Y 1 and P2Y 4 receptors, and FSH and TSH may coexist in the same endocrine cells. As such, doublelabeling immunostaining experiments were carried out to clarify this issue. The results showed that almost all of the P2Y 1 receptor-ir cells were also labeled by the P2Y 4 receptor antibody and vice versa (Fig. 5a, b, c) ; in addition, almost all of the FSH-ir cells were also labeled by the TSH antibody, and vice versa (Fig. 5d, e, f) . Tables 6 and 7 summarize the data of the coexistence of P2Y 1 and P2Y 4 One of the double-labeled cells (yellow in color) is indicated by a yellow arrow. Single-labeled FSH-ir and P2Y 2 -ir cells are also observed. A pink arrow and a blue arrow indicate a single labeled FSH-ir and P2Y 2 -ir cell, respectively. e Merged image of P2Y 2 -ir and TSH-ir cells. Note that there is no colocalisation. f a merged image of P2Y 2 receptor-ir (red) and S100-ir (green) cells. Note that almost all of the S100-ir cells are also labeled with P2Y 2 immunoreactivity, but a proportion of the P2Y 2 -ir cells are not labeled by S100 antibody, such as the one indicated by a red arrow. A yellow arrow indicates a double-labeled cell. All scale bars=60 μm receptors, and FSH and TSH in endocrine cells of the rat anterior pituitary, respectively.
Western blotting, performed on tissue extracts derived from the rat pituitary (Fig. 6a) , assessed the specificity of the polyclonal P2Y receptor antibodies. The immunoreactive bands were detected at different molecular weight levels: one band for the P2Y 1 receptor at about 48 kDa (Fig. 6a, lane 1) , two bands for the P2Y 2 receptor at about 36, 90 kDa (Fig. 6a, lane 3) , one band for the P2Y 4 at about 49 kDa (Fig. 6a, lane 5) , one band for the P2Y 13 receptor at about 37 kDa (Fig. 6a, lane 9) , but no clear bands for P2Y 6 and P2Y 12 receptors were found (Fig. 6a, lanes 7 and 8) . Preadsorption of the antiserums with the peptide antigens resulted in the absence of the bands (Fig. 6a, lanes 2, 4, 6 and 10), indicating that the antibodies detected the appropriate antigen sequences.
Control experiments were carried out with the P2Y antibodies preabsorbed with their own peptides. No staining was observed in those preparations incubated with antisera solutions preabsorbed with their own peptides, as shown for (Fig. 6b, c) . A further negative control, of omitting the primary antibodies, was also carried out. No staining was also observed in those preparations.
Discussion
The present study showed that corticotroph, gonadotroph, somatotroph, lactotroph, thyrotroph and follico-stellate cells in the anterior pituitary express at least one of the P2Y receptor family: the corticotroph, somatotroph, lactotroph and follico-stellate cells express P2Y 2 receptors; gonadotroph and thyrotroph express P2Y 1 , P2Y 2 and P2Y 4 receptors. The identity of a small subpopulation of cells with P2Y 13 receptors in the rat anterior pituitary is confirmed in this study. The results presented in this study are credible as strict control experiments were carried out. Firstly, no immunostaining in the pituitary sections was obtained in the control experiments where the P2Y antibodies were preabsorbed with their corresponding peptides or by omitting the P2Y antibodies. Secondly, preadsorption of the P2Y receptor antiserums with their corresponding peptide antigens resulted in the absence of bands, indicating that the antibody detects the appropriate antigen sequence, further confirming the specificity of these P2Y receptors.
There are eight receptors of the P2Y family that have been cloned, namely P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , P2Y 12 , P2Y 13 and P2Y 14 , all of which are G proteincoupled receptors. There are two subgroups of G proteins which P2Y receptors are coupled with, namely Gq and Gi. P2Y 1 , P2Y 2 , P2Y 4 and P2Y 6 receptors are linked to activation of phospholipase C (PLC), inositol lipid signaling and the mobilization of intracellular Ca 2+ , P2Y 12, P2Y 13 and P2Y 14 receptors are coupled with Gi protein 1 − S100 + cells/total number of S100 + cells×100 2 + S100 + /total number of P2Y 2 + cells×100; p8=number of P2Y 2 + S100 − /total number of P2Y 2 + cells×100; p9= number of FSH + P2Y 2 − /total number of TSH + cells×100; p10= number of PRL + P2Y 2 − /total number of PRL + cells×100; p11=number of P2Y 2 − TSH + cells/total number of TSH + cells×100; p12=number of P2Y 2 − S100 + /total number of S100 + cells×100 Table 2 Coexistence between P2Y receptors and pituitary hormones or S100 P2Y ACTH FSH GH PRL TSH S100
resulting in inhibition of cAMP formation and P2Y 11 (only in human) are coupled with Gs and Gq, resulting in increased cAMP [21] . Within the family of P2Y receptors, P2Y 1 , P2Y 12 and P2Y 13 receptors respond to ADP. P2Y 2 and P2Y 4 receptors respond to both ATP and UTP, and P2Y 6 receptors to UDP [1] . One question must be asked, where are the endogenous purines (ATP and ADP) and pyrimidines (UTP and UDP) released from in the anterior pituitary? Currently, the physiological sources of extracellular purines and pyrimidines required for activation of purinergic receptors in pituitary cells remains unknown. In general, neurons, neuroendocrine cells and platelets release ATP by Ca 2+ -controlled exocytosis of nucleotides stored within synaptic vesicles or dense core granules. The magnocellular neuroendocrine cells in the hypothalamus, that control release of vasopressin and oxytocin, also contain secretory ATP and could control the release of ATP [22] . Recently, the data was presented showing that ATP is also released by normal and immortalized anterior pituitary cells at resting conditions. Such basal ATP release was enhanced in cells simulated by ARL67156, an inhibitor of ectonucleotidases [13] . GnRH-induced stimulation of gonadotropin release was accompanied by elevation in basal ATP release, raising the possibility that ATP is stored in the secretory vesicles of these cells [2] . This is consistent with an earlier study showing calcium dependence of ATP release [23] . The roles of ATP as a neurotransmitter or cotransmitter are well established in the peripheral and central nervous systems [24] . Several reports have also suggested that ATP is secreted by skeletal muscle, adrenal chromaffin cells, mast cells, blood cells, fibroblasts and endothelial cells, pyrimidines are secreted by endothelial, epithelial and astrocytoma cells [24, 25] . The duration and distance of ATP actions are limited by several ecto-ATPases, which ensure that circulating levels of ATP are below that required for the global activation of purninceptors [7] . These previous data suggested that purines and pyrimidines could be released by the anterior pituitary cells and act as an autocrine/paracrine factor to be involved in the regulation of physiological functions of anterior pituitary endocrine cells.
Rat gonadotrophs show a potency order of ATP=ADP= UTP, suggesting the presence of P2Y 1 , P2Y 12 , P2Y 13 (ADP) and P2Y 2 and P2Y 4 (ATP=UTP) receptors [26] . UTP-sensitive receptors have been suggested to be present in gonadotrophs [16, 26] and lactotrophs [17] , but these results were not confirmed by other reports [2, 14] . The present results showed that gonadotrophs and lactotrophs express P2Y 4 and P2Y 2 receptors, respectively, the ligand for which is UTP, confirming that gonadotrophs and lactotrophs express UTP-sensitive receptors.
In this study, 91% and 95% of P2Y 1 receptor-ir cells in the rat anterior pituitary were labeled with FSH and TSH immunoreactivity, respectively. Almost all the P2Y 4 receptor-ir cells were labeled with FSH and TSH immunoreactivity. This result implies that at least a subpopulation of gonadotrophs and thyrotrophs co-express FSH and TSH in the rat anterior pituitary. In order to confirm this, we studied the coexistence of FSH and TSH in the anterior pituitary and found that almost all the gonadotrophs labeled by the FSH antibody were also labeled by the TSH antibody, which means that FSH and TSH coexist in the same endocrine cells in the anterior pituitary. A report showing that FSH and TSH coexist in the same endocrine cells of the musk shrew anterior pituitary has been published [27] . To our knowledge, this study is the first report that FSH and TSH coexist in the same endocrine cells of the rat pituitary. As the majority of gonadotrophs or thyrotrophs were found to express P2Y 1 or P2Y 4 receptors, this implies that P2Y 1 and P2Y 4 receptors may be coexpressed in a subpopulation of gonadotrophs and thyrotrophs. Further, double-labeling immunostaining confirmed that P2Y 1 and P2Y 4 receptors actually coexpress in the same endocrine cells in the anterior pituitary of the rat. As the endogenous ligands for P2Y 1 and P2Y 4 receptors are ADP and UTP, purines and pyrimidines may act on gonadotrophs and thyrotrophs at the same time if P2Y 1 4 + TSH − /total number of P2Y 4 + cells×100; p7=number of P2Y 4 + S100 + /total number of P2Y 4 + cells×100; p8= number of P2Y 4 + S100 − /total number of P2Y 4 + cells×100; p9=number of FSH + P2Y 4 − /total number of TSH + cells×100; p10=number of PRL + P2Y 4 − /total number of PRL + cells ×100; p11=number of P2Y 4 − TSH + cells/total number of TSH + cells×100; p12=number of P2Y 4 − S100 + cells/total number of S100 + cells×100
and P2Y 4 receptors were functionally expressed in these cells. This suggestion needs to be confirmed. The folliculo-stellate cells are glia-like cells in the anterior pituitary, which express nervous tissue-specific S100 protein [28] . The physiological functions of the folliculo-stellate cells are heterogeneous. They are involved in regulating the activity of the pituitary endocrine cells, act as immune cells such as macrophages and dendritic cells, and represent an adult stem cell population of the pituitary [29] . Previous data showed that both ATP and UTP increased the intracellular Ca 2+ concentration of primary cultured folliculo-stellate cells of the pituitary in a concentration-dependent manner in a range between 0.1 and 10 μM. The response was completely suppressed by thapsigargin, an inhibitor of endoplasmic reticulum [15] . In this study, strong immunostaining signals for P2Y 2 receptors were detected in the folliculo-stellate cells that were also stained with S100 in sections of the rat anterior pituitary. This result further confirmed the previous report that ATP/UTP, via P2Y 2 receptors released by autocrine or paracrine mechanisms, is involved in modulating the activity of folliculo-stellate cells.
In conclusion, the present study has shown that P2Y receptors are widely expressed in the anterior pituitary. P2Y 1 and P2Y 4 receptors are found to be expressed in the majority of gonadotrophs and thyrotrophs, P2Y 2 receptors are expressed in a small subpopulation of lactotrophs and almost all of the folliculo-stellate cells that are stained with S100 protein. The identity of a small subpopulation of P2Y 13 receptor-ir cells in the rat anterior pituitary still needs to be confirmed. The present results show that P2Y 1 and P2Y 4 receptors are co-expressed in a subpopulation of gonadotrophs and thyrotrophs. Purines and pyrimidines may act on gonadotrophs and thyrotrophs at the same time via P2Y 1 and P2Y 4 receptors. This result further confirmed the previous report that ATP/UTP, via P2Y 2 receptors released by an autocrine or paracrine mechanism, is involved in modulating the activity of folliculo-stellate cells.
